Alzheimer drug

<!-- -->Almost all Alzheimer's patients under the age of 30 have pathological gene mutations.A 19-year-old in China has been diagnosed with Alzheimer's disease becoming the youngest case of the condition ever reported, according to a…

Lecanemab, a drug, has been demonstrated during clinical trials to clear the brain's harmful amyloid protein and postpone the onset of Alzheimer's symptoms, making it the first treatment in the world to slow brain aging. In a Phase 3 trial,…